Seeking Clues to Biogen (BIIB) Q4 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 02/07/25
Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 02/05/25
Biogen Stock Down on Regulatory Update in the EU for Alzheimer's DrugZacks Investment Research • 02/03/25
Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease in the European UnionGlobeNewsWire • 01/31/25
BIIB Secures FDA Nod for Monthly Maintenance Dosing of Alzheimer's DrugZacks Investment Research • 01/27/25
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's DiseaseGlobeNewsWire • 01/26/25
Genetic Toxicology Testing Market Research 2024-2034: Increased R&D Activities, Strategic Collaborations, and a Focus on Personalized Therapy Boosts GrowthGlobeNewsWire • 01/23/25
Billionaire Sells Palantir Stock and Buys This Stock That Could Soar 64% According to a Wall Street Expert24/7 Wall Street • 01/21/25
Biogen Inc. (BIIB) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)Seeking Alpha • 01/15/25
FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's DiseaseGlobeNewsWire • 01/14/25
Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from BiogenBusiness Wire • 01/10/25
Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business OfficerBusiness Wire • 01/08/25